JAK2 and diabetic kidney disease: Podocyte-specific JAK2 overexpression has been found to accelerate disease progression in a DKD mouse model36, and a STAT3 inhibitor (S3I-201) can attenuate fibrosis and inflammation in UUO kidneys37.